Joshua Geleris MD
Hospital Medicine/Hospitalist
Internal Medicine at New York - Presbyterian Hospital
Join to View Full Profile
622 W 168th StNew York, NY 10032
Phone+1 212-305-2500
Fax+1 212-305-3213
Dr. Geleris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2014 - 2017
Technion-Israel Inst of Technology Faculty of MedicineClass of 2014
Certifications & Licensure
NY State Medical License 2017 - 2026
Publications & Presentations
PubMed
- Three hospitalized non-critical COVID-19 subphenotypes and change in intubation or death over time: A latent class analysis with external and longitudinal validation.William S Stringer, Amy S Labar, Joshua D Geleris, Evan V Sholle, David A Berlin
Plos One. 2025-01-01 - 2 citationsFibrotic-Like Pulmonary Radiographic Patterns Are Not Associated With Adverse Outcomes in COVID-19 Chronic Critical Illness.Purnema Madahar, Kathleen M Capaccione, Mary M Salvatore, Briana Short, Romina Wahab
Critical Care Medicine. 2023-11-01 - 1 citationsUsing clinical decision support tools to increase defibrillator deactivations in dying patients.Ramsey Kalil, Daniel Y Choi, Joshua D Geleris, Jennifer I Lee, Michael P Wagner
BMJ Open Quality. 2022-08-01
Journal Articles
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19Joshua Geleris, Neil W Schluger, The New England Journal of Medicine
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19Joshua Geleris, Neil W Schluger, The New England Journal of Medicine
Authored Content
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19May 2020
Press Mentions
The Efficacy and Safety of Hydroxychloroquine (HCQ) in Treatment of COVID19 –a Systematic Review and Meta-AnalysisMarch 26th, 2021- All Hands on DeckDecember 23rd, 2020
What Is Hydroxychloroquine? President Trump Calls It a COVID-19 Miracle Drug, but Many Scientists DisagreeMay 21st, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
